About us

About us

Nordic BioAnalyis rests in the vibrant biotech cluster Biovation park in Södertälje, Sweden. The company was founded in 2010 and in 2016 the name was changed to Nordic BioAnalysis with focus on analytical services, manufacturing solutions and stability studies. We currently possess 200 m2 laboratory space, with excellent opportunities for expansion. We are proud of our experienced team with passion for quality and analytical techniques.

Our team

Hongmei Yan

Ph.D., Lab Manager

Experienced in pharmaceutical and biopharmaceutical research as well as knowledge of DMPK, PK/PD modelling.

Hongmei.yan@norbab.com
Tel +46 (0)76-3936358

Navina Isenberg

QA and Site Manager

Pharmacist, with experience from building of various quality systems and leadership within small size pharma departments.

navina.isenberg@norbab.com
Tel +46 (0)739 038 184

image002 (1)

Sanny Santos

MPharm, Analytical Scientist

Pharmacist specialized in microbiology with more than 15 years of practical experience from quality control in GMP environment within multinational pharmaceutical companies.

Andrew (Lin Kiat) Lee

Ph.D. Immunology

Senior scientist in biomolecular science and microbiology. Andrew has vast research experience with cell culturing and different molecular biology techniques, driving projects for efficiency.

Satheesh Kumar lyappan B.Tech.

Analytical Chemist

Motivated and enthusiastic self-starter with work experience in both laboratory and technical support in the field of clinical research and pharmaceuticals. Extensive and varied experience in different analytical techniques, method development and validation of pharmaceutical products as well as QC documentation.

Ana Pinheiro

Ph.D., Scientist

Experienced researcher in molecular biology and biochemistry with strong skills on gene editing, protein chemistry, cell culture and immunohistochemistry.

Osei Ampomah

QA Specialist, Ph.D.

Microbiologist with experience in Quality Control and Quality Assurance. Have been actively involved in the approval process of microbiological methods for testing drug substance/products and medical devices based on Ph. Eur and USP.

Leo Groenewegen

CEO/VD

Trained Health Economist with over a decade of experience delivering strategic, commercial and financial excellence to companies active in Life Sciences, Biotech and Foodtech. Responsible for overall operational management of the business. Experience as founder/C-suite in various smaller and larger businesses.